View Older Stories View More Recent Stories

Mar 26, 2025 09:45AM Truist Weighs In on Obesity: 'Catalyst-Rich 2025 Ahead in a Growing Competitive Landscape'

Mar 25, 2025 11:28AM Organovo (ONVO) Announces Close of the Sale of FXR Program to Eli Lilly and Company (LLY)

Mar 25, 2025 10:12AM Bernstein on Eli Lilly (LLY): 'We Like the Lead that Retatrutide Has'

Mar 24, 2025 12:54PM Investment commitments in U.S. nears $3 trillion since Trump took office

Mar 24, 2025 10:17AM Jefferies Reiterates Buy Rating on Eli Lilly (LLY)

Mar 24, 2025 09:00AM UBS Reiterates Buy Rating on Eli Lilly (LLY)

Mar 18, 2025 07:57AM Bernstein on Eli Lilly (LLY): 'LLY Takes Majority Share & Anti-Cancer Potential for Retatrutide'

Mar 18, 2025 06:52AM Cantor Fitzgerald says more options, newer targets will expand obesity market

Mar 16, 2025 10:00AM Will Pfizer step into the obesity ring? Wolfe Research answers

Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma

Mar 15, 2025 04:00AM How could tariffs shake up the pharma sector?

Mar 10, 2025 08:02AM Morgan Stanley Reiterates Overweight Rating on Eli Lilly (LLY)

Mar 7, 2025 08:32AM Eli Lilly's (LLY) EBGLYSS single monthly maintenance injection achieved completely clear skin at three years in half of patients with moderate-to-severe atopic dermatitis

Mar 6, 2025 08:52AM Teladoc (TDOC) +2% on addition of GLP-1 self-pay option with Lilly

Mar 6, 2025 07:59AM Bernstein Reiterates Market Perform on Novo Nordisk (NOVOB:DC) (NVO) Following NovoCare Pharmacy Launch

Mar 5, 2025 09:26AM Amgen (AMGN) Starts Late-stage Studies Of Monthly Obesity Drug - Bloomberg, Citing Comments at Conf.

Mar 5, 2025 07:44AM Bernstein on Eli Lilly (LLY): '2025 is a Catalyst-Rich Year for LLY'

Mar 4, 2025 06:49AM Bernstein: 'Eli Lilly (LLY) Continues to Outgrow Novo'

Feb 28, 2025 08:15AM Lilly's (LLY) Jaypirca recommended by CHMP for approval in EU for adults with r/r CLL

Feb 28, 2025 07:48AM Bernstein on Eli Lilly (LLY) Amid US Biopharma Policy: 'LLY Leans In'

Feb 26, 2025 02:01PM Eli Lilly to invest another $27 billion in U.S. manufacturing

Feb 26, 2025 12:19PM Deutsche Bank Reiterates Buy Rating on Eli Lilly (LLY) Amid New U.S. Investment

Feb 26, 2025 10:00AM JPMorgan Reiterates Overweight Rating on Eli Lilly (LLY)

Feb 26, 2025 09:30AM Eli Lilly & Co. (LLY) to more than double U.S. manufacturing investment since 2020 exceeding $50B

Feb 26, 2025 09:23AM BMO Capital Reiterates Outperform on Eli Lilly (LLY) After Self Pay Program Expansion

Feb 26, 2025 06:39AM Eli Lilly (LLY) Lowers Zepbound Price; Bernstein: 'This is Something We'd Been Hoping to See'

Feb 25, 2025 08:06AM Organovo's (ONVO) FXR Program, including FXR314, Acquired by Eli Lilly (LLY)

Feb 25, 2025 06:46AM Eli Lilly & Co. (LLY) launches additional Zepbound vial doses and offers new savings for self-pay patients

Feb 24, 2025 07:19AM Bernstein Sees 'Clear Upside' for Eli Lilly's (LLY) Zepbound and Mounjaro Post FDA Announcement

Feb 22, 2025 04:00AM What's the current state of China's GLP-1 market?

Feb 21, 2025 11:31AM Eli Lilly & Co. (LLY) call put ratio 3.9 calls to 1 put as share price up 2.2%

Feb 20, 2025 05:30AM Eli Lilly & Co. (LLY) call put ratio 1.8 calls to 1 put amid price movement

Feb 19, 2025 04:19PM Eli Lilly & Co. (LLY) Files Mixed Shelf

Feb 10, 2025 05:37PM Eli Lilly announces $6.5 billion six-part note offering

Feb 7, 2025 06:45AM Eli Lilly & Co. (LLY) reports most patients on Omvoh for Crohn's disease achieved sustained clinical remission and endoscopic response at two years

Feb 6, 2025 06:47AM Eli Lilly & Co. (LLY) Tops Q4 EPS by 2c; offers outlook

Feb 6, 2025 05:59AM Bernstein on Eli Lilly (LLY) Following NOVO Read-Across: 'Good News for LLY'

Feb 6, 2025 05:49AM Eli Lilly & Co. (LLY) call put ratio 1.6 calls to 1 put into quarter results

Feb 6, 2025 02:00AM Eli Lilly Q4 earnings preview: Here’s what to expect

Feb 5, 2025 01:35PM Erste Group Upgrades Eli Lilly (LLY) to Buy

Feb 5, 2025 01:20PM Truist Securities Reiterates Buy Rating on Eli Lilly (LLY)

Feb 5, 2025 10:37AM Eli Lilly & Co. (LLY) call put ratio 1.4 calls to 1 put into quarter results

Feb 5, 2025 05:16AM Eli Lilly & Co. (LLY) call put ratio 1.7 calls to 1 put into quarter results

Feb 3, 2025 08:50AM Eli Lilly (LLY) PT Raised to $1,038 at Truist on 'Updated FY2024 and Announced FY2025 Guidance'

Jan 30, 2025 01:12PM Eli Lilly & Co. (LLY), Novo (NVO) see mid-day upside

Jan 28, 2025 02:55PM Tectonic shares tumble after rival drug trial termination

Jan 28, 2025 02:50PM Leerink Comments on Tectonic Therapeutics Inc. (TECX) Post Eli Lilly (LLY) Terminating volenrelaxin CKD

Jan 27, 2025 06:37AM Bernstein Reiterates Outperform Rating on Eli Lilly (LLY): 'Novo Punches Back, but LLY Still a Step Ahead'

Jan 24, 2025 12:14PM BofA Securities Reiterates Buy Rating on Eli Lilly (LLY)

Jan 23, 2025 10:00PM Eli Lilly & Co. (LLY) Morgan Stanley sees three potential scenarios in the compounders vs. FDA over Tirzepatide

View More Recent Stories View Older Stories